Kristen Krueger
Medical · West Bloomfield, MINPI 1891800769
Payments from drug & device makers
Across 217 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$583
- Novo Nordisk$494
- GSK$409
- Pfizer$336
- AbbVie$219
- AstraZeneca$184
- plus $1K from 32 others
What the payments were for
- Food & beverage$3,706100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 38 | $583 |
| Novo Nordisk | 35 | $494 |
| GSK | 28 | $409 |
| Pfizer | 20 | $336 |
| AbbVie | 12 | $219 |
| AstraZeneca | 11 | $184 |
| Medline Industries LP | 1 | $133 |
| Amgen | 7 | $117 |
| Exact Sciences | 5 | $114 |
| Merck | 5 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $90 |
| Biohaven Pharmaceuticals, Inc. | 5 | $75 |
| Boehringer Ingelheim | 4 | $73 |
| Abbott | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Harmony Biosciences LLC | 3 | $61 |
| Johnson & Johnson(2 entities) | 4 | $60 |
| Indivior Inc. | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Sanofi-aventis U.S. LLC | 2 | $49 |
| Astellas Pharma US Inc | 2 | $39 |
| Novartis | 2 | $32 |
| Corcept Therapeutics | 1 | $29 |
| Impel Pharmaceuticals Inc. | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Nestle Healthcare Nutrition Inc. | 2 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Axonics, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Abiomed | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Alk-abello, Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$3,706 in reported general payments places this provider in the 80th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $40,630 |
| JardianceEmpagliflozin | 26 | $28,549 |
| JanuviaSitagliptin Phosphate | 23 | $24,462 |
| EliquisApixaban | 18 | $22,619 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $14,198 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $10,652 |
| FarxigaDapagliflozin Propanediol | 17 | $10,599 |
| Atorvastatin Calcium | 266 | $3,088 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,913 |
| Omeprazole | 148 | $2,273 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,747 |
| Levothyroxine Sodium | 119 | $1,445 |
| Losartan Potassium | 113 | $1,442 |
| Ventolin HfaAlbuterol Sulfate | 14 | $1,384 |
| Duloxetine Hcl | 60 | $1,334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $494 | $40,63019 claims |
| Boehringer IngelheimJardiance | $73 | $28,54926 claims |
| MerckJanuvia | $91 | $24,46223 claims |
| PfizerEliquis | $336 | $22,61918 claims |
| AstraZenecaFarxiga, Symbicort | $184 | $13,51229 claims |
| GSKTrelegy Ellipta | $409 | $10,65215 claims |
| AbbVieSynthroid | $219 | $85211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 755 medical providers in Michigan.
Other medical in West Bloomfield
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.